Exenatide, a type of synthetic exendin-4, is a stable analogue of glucagon-like peptide 1, which has been approved for the clinical use against type 2 diabetes mellitus (Nathanson et al. 2009). The gene discussed is GCG; the disease is diabetes mellitus.